# US 2026/0083814 A1 · Dietary supplement formulation and method of preparation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083814 A1
- Document ID: US20260083814A1
- Status: Published application
- Kind: A1
- Application number: 18/896,966
- Filed: 2024-09-26
- Published: 2026-03-26
- Earliest claimed: 2024-09-26
- Inventors: Darius Jones
- Web page: https://patentgrep.com/patent/US20260083814A1

## CPC

- A61K 36/9066: Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
- A61K 9/4833: {Encapsulating processes; Filling of capsules (mechanical aspects A61J3/07)}
- A61K 31/047: having two or more hydroxy groups, e.g. sorbitol
- A61K 31/10: Sulfides; Sulfoxides; Sulfones
- A61K 31/12: Ketones
- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A61K 31/4525: containing a five-membered ring with oxygen as a ring hetero atom
- A61K 31/593: 9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A61K 31/714: Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/324: Boswellia, e.g. frankincense
- A61K 36/67: Piperaceae (Pepper family), e.g. Jamaican pepper or kava
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The disclosure provides a dietary supplement formulation to alleviate sciatica pain, support nerve health, and enhance musculoskeletal health. The formula comprises a synergistic blend of natural ingredients, each selected for its specific properties. The formulation includes a Turmeric Extract (200 mg) for its anti-inflammatory and antioxidant effects, Myo-Inositol Powder (300 mg) for nerve signal transmission, MSM 80 Mesh (300 mg) for reducing inflammation and supporting connective tissue, and Black Currant Extract (250 mg) for its antioxidant properties. Omega 3 Fatty Acid (40 mg) provides anti-inflammatory and neuroprotective benefits, BioPerine (5 mg) enhances ingredient bioavailability, Magnesium (30 mg) supports nerve function and muscle relaxation, Vitamin D3 (10 mcg) is essential for bone health, Vitamin B12 (500 mcg) maintains healthy nerve cells, and Boswellia serrata Extract (100 mg) reduces inflammation.

## Claims

### Claim 1

A dietary supplement formulation for alleviating sciatica pain, supporting nerve health, and enhancing musculoskeletal health, comprising:
Turmeric Extract in an amount of 200 mg, providing anti-inflammatory and antioxidant properties to alleviate inflammation and protect nerve cells;
Myo-Inositol Powder in an amount of 300 mg, supporting nerve signal transmission and osmotic regulation to reduce nerve pain and promote optimal nerve health;
MSM 80 Mesh in an amount of 300 mg, delivering anti-inflammatory and analgesic effects to reduce inflammation and support connective tissue integrity;
Black Currant extract in an amount of 250 mg, rich in antioxidants to neutralize free radicals, reduce oxidative stress, and improve blood circulation;
Omega 3 Fatty Acid in an amount of 40 mg, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), providing anti-inflammatory and neuroprotective benefits;
BioPerine Piper nigrum fruit extract in an amount of 5 mg, enhancing the bioavailability of other ingredients;
Magnesium in an amount of 30 mg, contributing to nerve function and muscle relaxation;
Vitamin D3 in an amount of 10 mcg, essential for bone health and reducing inflammation;
Vitamin B12 in an amount of 500 mcg, vital for maintaining healthy nerve cells and supporting nervous system function; and
Boswellia serrata Extract in an amount of 100 mg, providing anti-inflammatory properties to address musculoskeletal health.

### Claim 2 (depends on 1)

The dietary supplement formulation of claim 1, wherein the turmeric extract comprises 95% curcuminoids and is included in an amount effective to reduce sciatic nerve inflammation.

### Claim 3 (depends on 1)

The dietary supplement formulation of claim 1, wherein the turmeric extract is extracted from the root of Curcuma longa plant.

### Claim 4 (depends on 1)

The dietary supplement formulation of claim 1, wherein the myoinositol powder is a Vitamin B8.

### Claim 5 (depends on 1)

The dietary supplement formulation of claim 1, wherein the MSM 80 mesh is methylsulfonylmethane.

### Claim 6 (depends on 1)

The dietary supplement formulation of claim 1, wherein the black currant extract is in a ratio of 4:1.

### Claim 7 (depends on 1)

The dietary supplement formulation of claim 1, wherein the black currant extract is in the powder form.

### Claim 8 (depends on 1)

The dietary supplement formulation of claim 1, wherein the black currant extract is extracted from the shrubs Ribes nigrum i.e. berry.

### Claim 9 (depends on 1)

The dietary supplement formulation of claim 1, wherein the omega 3 fatty acids, including EPA and DHA, are included in an amount effective to reduce inflammation and maintain nerve cell membrane integrity.

### Claim 10 (depends on 1)

The dietary supplement formulation of claim 1, wherein the BioPerine Piper nigrum fruit extract is standardized to a minimum of 95% piperine.

### Claim 11 (depends on 1)

The dietary supplement formulation of claim 1, wherein BioPerine Piper nigrum fruit extract is in a powder form.

### Claim 12 (depends on 1)

The dietary supplement formulation of claim 1, wherein the magnesium is a Magnesium Citrate powder.

### Claim 13 (depends on 1)

The dietary supplement formulation of claim 1, wherein the Boswellia serrata Extract is standardized to 65% boswellic acid.

### Claim 14 (depends on 1)

The dietary supplement formulation of claim 1, wherein the other ingredients are Magnesium stearate and silicon dioxide.

### Claim 15

A method for the preparation of a dietary supplement formulation, comprising:
sourcing high-quality, pure ingredients that are subjected to quality checks to ensure they meet purity and quality standards through standardized testing procedure;
weighing and mixing the ingredients, wherein the ingredients are accurately weighed and uniformly mixed to achieve a consistent blend;
encapsulating the mixture, wherein the uniformly mixed ingredient blend is filled into capsules using an encapsulation machine;
conducting quality control checks on the capsules, wherein the checks include assessing weight uniformity, disintegration time, and other relevant quality parameters;
packaging the approved capsules, wherein the capsules are placed into suitable containers and labeled with the necessary product information; and
performing a final inspection of the packaged product to ensure it meets all quality and safety standards before distribution.

### Claim 16 (depends on 15)

The method of claim 15, wherein the weighing and mixing step involves using precision equipment to ensure accurate measurement and homogeneous distribution of the ingredients.

### Claim 17 (depends on 15)

The method of claim 15, wherein the encapsulation step uses an encapsulation machine designed to ensure precise filling of the capsules with the mixed ingredient blend.
